Academic literature on the topic 'Brand-name pharmaceutical company'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Brand-name pharmaceutical company.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Brand-name pharmaceutical company"
Xie, Jin, and Joseph Gerakos. "The Anticompetitive Effects of Common Ownership: The Case of Paragraph IV Generic Entry." AEA Papers and Proceedings 110 (May 1, 2020): 569–72. http://dx.doi.org/10.1257/pandp.20201029.
Full textLexchin, Joel, Sharon Batt, Devorah Goldberg, and Adrienne Shnier. "National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study." BMJ Open 12, no. 3 (March 2022): e055287. http://dx.doi.org/10.1136/bmjopen-2021-055287.
Full textLiang, Zhiwen. "Regulatory exclusivity protection for undisclosed test data in China: an innovative approach to implementing the TRIPS Agreement." Queen Mary Journal of Intellectual Property 10, no. 1 (February 19, 2020): 115–27. http://dx.doi.org/10.4337/qmjip.2020.01.05.
Full textRosina, Mônica Steffen Guise, and Lea Shaver. "Why are Generic Drugs Being Held up in Transit? Intellectual Property Rights, International Trade, and the Right to Health in Brazil and beyond." Journal of Law, Medicine & Ethics 40, no. 2 (2012): 197–205. http://dx.doi.org/10.1111/j.1748-720x.2012.00658.x.
Full textMistry, Vimesh R., Neeta J. Kanani, and Kuntal S. Thacker. "A critical evaluation of promotional drug literatures available with prescribers at a tertiary care teaching hospital in Gujarat, India." International Journal of Basic & Clinical Pharmacology 11, no. 2 (February 23, 2022): 167. http://dx.doi.org/10.18203/2319-2003.ijbcp20220417.
Full textHarrop, Chris, John Read, Jim Geekie, and Julia Renton. "An Independent Audit of Pharma Influence in Public Mental Health Trusts in England." Ethical Human Psychology and Psychiatry 20, no. 3 (December 1, 2018): 156–68. http://dx.doi.org/10.1891/1559-4343.20.3.156.
Full textKaras, Laura. "Privacy as the Price of Drug Access." Science and Technology Law Review 23, no. 1 (March 7, 2022): 50–141. http://dx.doi.org/10.52214/stlr.v23i1.9390.
Full textDass, Ervilla. "An observational study of various drug promotional advertising brochures: with an emphasis on World Health Organization ethical criteria for medicinal drug promotion." International Journal of Basic & Clinical Pharmacology 7, no. 7 (June 22, 2018): 1280. http://dx.doi.org/10.18203/2319-2003.ijbcp20182425.
Full textChadha, Alka. "Daiichi Sankyo's generic (mis) adventure: the Ranbaxy takeover." Emerald Emerging Markets Case Studies 2, no. 8 (October 17, 2012): 1–10. http://dx.doi.org/10.1108/20450621211308122.
Full textLi, Xing, and Minyue Jin. "Technology transfer in prescription drug market." Journal of Modelling in Management 13, no. 2 (May 14, 2018): 495–518. http://dx.doi.org/10.1108/jm2-03-2017-0029.
Full textBooks on the topic "Brand-name pharmaceutical company"
Veatch, Robert M., Amy Haddad, and E. J. Last. Health Insurance, Health System Planning, and Rationing. Edited by Robert M. Veatch, Amy Haddad, and E. J. Last. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190277000.003.0015.
Full textConference papers on the topic "Brand-name pharmaceutical company"
Kamijo, Koichi. "Future Sales Estimation using Patents." In 9th International Conference on Computational Science and Engineering (CSE 2021). Academy and Industry Research Collaboration Center (AIRCC), 2021. http://dx.doi.org/10.5121/csit.2021.112404.
Full text